ATE310019T1 - Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis - Google Patents

Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis

Info

Publication number
ATE310019T1
ATE310019T1 AT00949595T AT00949595T ATE310019T1 AT E310019 T1 ATE310019 T1 AT E310019T1 AT 00949595 T AT00949595 T AT 00949595T AT 00949595 T AT00949595 T AT 00949595T AT E310019 T1 ATE310019 T1 AT E310019T1
Authority
AT
Austria
Prior art keywords
citrulline
aab
detecting
diagnostics
treatment
Prior art date
Application number
AT00949595T
Other languages
English (en)
Inventor
Guy Serre
Mireille Sebbag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE310019T1 publication Critical patent/ATE310019T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00949595T 1999-07-01 2000-06-30 Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis ATE310019T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9908470A FR2795735B1 (fr) 1999-07-01 1999-07-01 Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoide
PCT/FR2000/001857 WO2001002437A1 (fr) 1999-07-01 2000-06-30 Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoïde

Publications (1)

Publication Number Publication Date
ATE310019T1 true ATE310019T1 (de) 2005-12-15

Family

ID=9547577

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949595T ATE310019T1 (de) 1999-07-01 2000-06-30 Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis

Country Status (9)

Country Link
US (2) US7022485B1 (de)
EP (2) EP1619205A1 (de)
JP (1) JP4794102B2 (de)
AT (1) ATE310019T1 (de)
CA (1) CA2377957C (de)
DE (1) DE60024092T2 (de)
ES (1) ES2253241T3 (de)
FR (1) FR2795735B1 (de)
WO (1) WO2001002437A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795735B1 (fr) * 1999-07-01 2001-09-07 Univ Toulouse Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoide
SI1341819T1 (sl) * 2000-12-12 2006-10-31 Fibrex Medical Res & Dev Gmbh Uporaba fibrinskih/fibrinogenskih peptidov in proteinov za pripravo zdravila
NL1019540C2 (nl) 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
EP1882946B1 (de) * 2003-12-23 2010-02-17 Roche Diagnostics GmbH Methode zur Beurteilung von rheumatoider Arthritis durch Bestimmung von Anti-CCP und Interleukin 6
WO2005075414A1 (ja) * 2004-02-04 2005-08-18 Yokohama City University ぺプチジルアルギニンデイミナーゼ４阻害剤
US8472990B2 (en) 2004-07-23 2013-06-25 St Ericsson Sa Apparatus using interrupts for controlling a processor for radio isolation and associated method
US8207299B2 (en) * 2004-11-04 2012-06-26 Biomerieux Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof
FR2877345B1 (fr) * 2004-11-04 2007-01-12 Biomerieux Sa Peptides citrullines derives de la fibrine reconnus par des auto-anticorps specifiques de la polyarthrite rhumatoide, et leurs utilisations
FR2879604B1 (fr) * 2004-12-22 2010-08-13 Biomerieux Sa Peptides citrullines derives de la fibrine reconnus par des auto-anticorps specifiques de la polyarthrite rhumatoide, et leurs utilisations
FR2900657B1 (fr) * 2006-05-03 2009-04-17 Univ Toulouse Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide
ES2307421B1 (es) * 2007-04-30 2009-09-28 Consejo Superiorde Investigaciones Cientificas (Csic) Polipeptido quimerico fibrina-filagrina citruinado capaz de detectar los anticuerpos generados en la artritis reumatoide.
US8323656B2 (en) * 2007-06-25 2012-12-04 Yijun Xu Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
US8062852B2 (en) 2007-10-01 2011-11-22 The Children's Hospital And Regional Medical Center Detection and treatment of autoimmune disorders
FR2908134B1 (fr) * 2007-12-04 2012-10-12 Univ Toulouse 3 Paul Sabatier Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide
US20100203553A1 (en) * 2009-02-11 2010-08-12 Abdeen Suad M Histochemical and biomarker for liver fibrosis
US9140701B2 (en) * 2009-08-18 2015-09-22 The Board Of Trustees Of The Leland Stanford Junior University Fibrinogen immune complexes to diagnose and guide therapy in rheumatoid arthritis
EP2325195A1 (de) 2009-11-23 2011-05-25 Toscana Biomarkers S.r.l. Virale citrullinierte Peptide und Verwendungen dafür
EP2402368A1 (de) 2010-07-02 2012-01-04 Toscana Biomarkers S.r.l. Histoncitrullinierte Peptide und deren Verwendungen
EP2527841A1 (de) 2011-05-25 2012-11-28 Toscana Biomarkers S.r.l. Verfahren zur Diagnose rheumatoider Arthritis
WO2019246537A1 (en) * 2018-06-21 2019-12-26 President And Fellows Of Harvard College Fibrous proteinaceous networks and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520733A (en) 1946-08-26 1950-08-29 Shell Dev Polymers of trimethylene glycol
US3188353A (en) 1960-09-17 1965-06-08 Bayer Ag Method of preparing polyethers
US3326985A (en) 1964-12-29 1967-06-20 Shell Oil Co Polytrimethylene glycol
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
DE3346097A1 (de) 1983-12-21 1985-07-04 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von polyglycerinen
JPH06503113A (ja) 1990-11-27 1994-04-07 コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガナイゼーション ポリ（アルキレンオキシド）類
US5599790A (en) * 1992-06-11 1997-02-04 The Scripps Research Institute Fibrinogen γ chain polypeptide and compositions thereof
DE4316245A1 (de) 1993-05-14 1994-11-17 Henkel Kgaa Polyalkylenglykol
DE69435072T2 (de) * 1993-11-02 2009-01-29 Mitsubishi Kagaku Iatron, Inc. Antikörper gegen menschliches lösliches fibrin, hybridome, die sie produzieren und immunmessverfahren
US5858723A (en) * 1995-12-05 1999-01-12 Behringwerke Aktiengesellschaft Polypeptides and antibodies for diagnosing and treating seminoma
US5659089A (en) 1996-05-22 1997-08-19 Arco Chemical Technology, L.P. Process for making poly(2-methyl-1,3-propanediol)
NL1004539C2 (nl) * 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide afgeleid van een door auto-antilichamen van patiënten met reumatoïde artritis herkend antigeen, antilichaam daartegen en werkwijze voor het detecteren van auto-immuunantilichamen.
FR2795735B1 (fr) * 1999-07-01 2001-09-07 Univ Toulouse Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoide
EP1246861B1 (de) 1999-12-17 2006-05-17 E.I. Du Pont De Nemours And Company Herstellung von polytrimethylene ether glycol und copolymere davon
KR100677808B1 (ko) 1999-12-17 2007-02-05 이 아이 듀폰 디 네모아 앤드 캄파니 폴리트리메틸렌 에테르 글리콜의 연속 제조 방법

Also Published As

Publication number Publication date
US7022485B1 (en) 2006-04-04
DE60024092T2 (de) 2006-08-03
ES2253241T3 (es) 2006-06-01
EP1196450A1 (de) 2002-04-17
DE60024092D1 (de) 2005-12-22
US7445903B2 (en) 2008-11-04
EP1619205A1 (de) 2006-01-25
WO2001002437A1 (fr) 2001-01-11
JP4794102B2 (ja) 2011-10-19
EP1196450B1 (de) 2005-11-16
JP2003504314A (ja) 2003-02-04
FR2795735B1 (fr) 2001-09-07
CA2377957C (fr) 2012-05-29
CA2377957A1 (fr) 2001-01-11
US20070009507A1 (en) 2007-01-11
FR2795735A1 (fr) 2001-01-05

Similar Documents

Publication Publication Date Title
DE60024092D1 (de) Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis
NO952869D0 (no) Aminosyrederivater, medikamenter inneholdende disse forbindelser og fremgangsmåter for fremstilling derav
EP0960936A4 (de) Rekonstituierter menschlicher anti-hm.1 antikörper
DK0493480T3 (da) Dehydrodidemnin B
DE69006306D1 (de) Synthetische peptide des konjugates von ubiquitin und histon h2a.
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
LU91015I2 (fr) Recombinate (Rurioctocog alfa) dans toutes ses formes couvertes par le brevet de base
EP1427744A4 (de) System zur antikörperexpression und- synthese
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
DK0526544T3 (da) Terapeutiske anvendelser af actinbindende forbindelser
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
DE69312513D1 (de) MENSCHLICHE CYCLOOXYGENASE-2cDNA UND BESTIMMUNG VON MENSCHLICHE CYCLOOXYGENASE-2-INHIBIERUNG
FI860153A0 (fi) Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning.
DE69510810D1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
FI104252B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidien kemialliseksi syntetisoimiseksi kiinteässä faasissa
DK0914331T3 (da) Neuroaktive peptider
RU2002123877A (ru) Кахалалидные соединения
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
SE8802944D0 (sv) Materials for patch testing
ATE24917T1 (de) Peptide-derivate, deren herstellung und verwendung als elastasehemmende mittel.
DE59913620D1 (de) Diagnostikum und Therapeutikum zur Behandlung der autoimmunen Hepatitis
ATE48142T1 (de) Blutprotein, verfahren zu seiner herstellung, antikoerper gegen dieses protein und dieses protein oder diese antikoerper enthaltende pharmazeutische zubereitungen.
FR2709492B1 (fr) Méthode d'immunodosage spécifique de la glutathion peroxydase plasmatique humaine, kit pour sa mise en Óoeuvre, oligopeptides et anticorps spécifiques de la méthode .
BR0308095A (pt) Teste para anticorpos anti-ingap

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties